SPIE Photonics West 2024 Opens for Registration
Registration has opened for SPIE Photonics West 2024, which will run from 27 January to 1 February at the Moscone Center in San Francisco. The largest annual conference and exhibition in optics and photonics, the week will include more than 4,500 technical presentations as well as showcasing over 1,200 companies in three focused exhibitions. Photonics West brings together researchers, innovators, engineers, and business leaders from across the globe for an engaging week of research sharing, collaboration forming, and innovation-inspiring exchanges.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231005492002/en/
Attendees at SPIE Photonics West 2023 (Photo: Business Wire)
SPIE Photonics West has four major application areas emphasizing the latest technologies and discoveries that utilize optics and photonics. BiOS highlights new research in biophotonics, biomedical optics, and imaging for diagnostics and therapeutics; LASE focuses on the laser industry and its diverse applications; OPTO covers optoelectronics, photonic materials, and optical devices; and, now in its third year, Quantum West features quantum 2.0 technologies from quantum sensing and information systems to quantum enabled materials and devices and quantum biology. This year, Quantum West will also include a Quantum West Business Summit highlighting the work of moving quantum technologies to market.
Featuring more than 1,200 companies with product launches, live demonstrations, and cutting-edge technologies on display, the accompanying exhibitions during Photonics West provide terrific platforms for the diverse and healthy photonics industry.
“The demand for exhibition space at Photonics West is always a great indicator of the health of our industry, and this year, we've responded to increased demand by expanding the footprint 15% over last year’s and expect to sell out once again,” said SPIE Global Exhibition Services Director Bonnie Peterson. “We’re excited to welcome returning and new companies and look forward to offering our exhibitor community an engaging platform for their technologies, applications, and market-ready systems and components.”
New this year, the Quantum West Expo, 30-31 January, will showcase worldwide providers of the latest quantum technologies. The BiOS Expo — featuring new and transformative technologies in biomedical optics and healthcare applications — runs 27-28 January, while the Photonics West Exhibition, 30 January to 1 February, encompasses the latest from laser manufacturers and suppliers as well as other innovative optics and photonics devices, components, systems, and services. In addition, the dynamic industry program also returns with a renewed focus on the markets and applications shaping the photonics industry. All three exhibitions and the industry program are free to attend with a SPIE Photonics West registration.
The vibrant, event-packed week will cover the latest technologies and industry developments across the optics and photonics spectrum, from the SPIE BiOS Hot Topics and conference plenary sessions to the Prism Awards and the SPIE Startup Challenge. Highlighting the latest innovative research breakthroughs are the dynamic Hot Topics and plenary speakers, including Lingyan Shi, University of California, San Diego; Giuliano Scarcelli, University of Maryland; Paul Beard, University College London; Ben Vakoc, Wellman Center for Photomedicine, Massachusetts General Hospital, and Harvard Medical School; Philip Tinnefeld, LMU-Munich; Charles Lin, Massachusetts General Hospital Center for Systems Biology; Ryan Field, Kernel; Michelle Digman, University of California, Irvine; Jun Ye, JILA; Stephanie Simmons, Photonic, Inc; Marlan Scully, Texas A&M; Paul Prucnal, Princeton University; Åsa Haglund, Chalmers; Roel Baets, Ghent University/imec; Ahmed Diallo, ARPA-E; Akira Furusawa, University of Tokyo and RIKEN; LauraNaLiu, University of Stuttgart; Siddharth Ramachandran, Boston University; Bruce Tromberg, National Institutes of Health; R. Rox Anderson, Wellman Center for Photomedicine, Massachusetts General Hospital, and Harvard Medical School; Griff Harsh, University of California, Davis; Mary Lou Jepsen, Openwater; Cynthia Toth, Duke University; and Eric Henderson, Dartmouth-Hitchcock Medical Center.
Alongside the conferences and exhibitions, Photonics West will also offer 57 technical courses, including the popular Quantum Computing: A Concise Introduction, as well as eight new courses on topics such as inverse design for photonics, trends in miniature camera technology, photoacoustic imaging, and optical design for AR/VR/MR technologies.
The wide-ranging educational program complements numerous professional development workshops, a comprehensive job fair, and valuable networking opportunities for technical attendees, SPIE Members, and exhibitors.
Full conference registration for Photonics West includes access to the three-day SPIE AR | VR | MR event, which focuses on augmented, virtual, and mixed reality and the vital role that optics and photonics play in hardware and headset development. This popular program incorporates more than 30 invited industry talks, keynotes, and panels with speakers representing a range of exciting companies, including META, Oppo, XREAL, and Magic Leap; a two-day exhibition; and a headset museum featuring more than 100 headsets from the late 1980s to the present day.
This year, SPIE will also introduce its inaugural Global Business Forum. This one-day informational and networking opportunity held on 29 January, with a focus on current and emerging trends across the international optics and photonics industry and markets, will include insights from Tematys’ Thierry Robin, Yole Group’s Jean-Christophe Eloy, BOS Photonics’ Bo Gu; and Harlin’s John Lincoln, among others. Registration for the Global Business Forum is separate from Photonics West and will be available via the event website.
“Photonics West 2024 promises to be an engaging and thought-provoking week of networking and learning opportunities,” said SPIE Senior Director of Technical Programs Marilyn Gorsuch. “We are particularly excited to be expanding our Quantum West programming, including the addition of a quantum-focused exhibit. As the first major community gathering of the year, we continue to bring together a unique nexus of industry leaders and highly regarded researchers whose collaborations drive products, innovation, and technical breakthroughs. We expect an increase from last year’s 22,000 registered attendees and invite you to join the global photonics community and experience all that Photonics West 2024 has to offer.”
For more information and to register, please visit https://spie.org/pw.
About SPIE
SPIE, the international society for optics and photonics, brings engineers, scientists, students, and business professionals together to advance light-based science and technology. The Society, founded in 1955, connects and engages with our global constituency through industry-leading conferences and exhibitions; publications of conference proceedings, books, and journals in the SPIE Digital Library; and career-building opportunities. Over the past five years, SPIE has contributed more than $22 million to the international optics community through our advocacy and support, including scholarships, educational resources, travel grants, endowed gifts, and public-policy development. www.spie.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231005492002/en/
Contact information
Daneet Steffens
Public Relations Manager
daneets@spie.org
+1 360 685 5478
@SPIEtweets
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Nexo Announces Landmark Crypto Partnership with Tennis Australia for Australian Open and Summer of Tennis17.12.2025 09:00:00 CET | Press Release
Nexo, the premier digital assets platform, has entered a landmark multi-year global partnership with Tennis Australia, becoming the Official Crypto Partner of the Australian Open and the Summer of Tennis, including the United Cup, Adelaide International, Brisbane International, and Hobart International. This agreement marks the first time a digital asset company has partnered with a Grand Slam tournament, affirming Nexo’s prestige, long-term vision, and leadership at the intersection of elite sport and digital assets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216497915/en/ Antoni Trenchev, Co-founder, Nexo, noted: “The Australian Open stands at the intersection of excellence and ambition – precisely where Nexo positions itself. Our partnership reflects a shared commitment to disciplined performance and long-term thinking. We are honored to join Tennis Australia in elevating the sport while showcasing the value of int
Jerrod Chong, Yubico ’ s Chief Operating Officer, appointed as acting CEO17.12.2025 08:05:00 CET | Press Release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and the leading provider of hardware authentication security keys, today announced that Jerrod Chong, Yubico’s current Chief Operating Officer, has been appointed to serve as acting CEO. Mattias Danielsson will be stepping down from his role as CEO of Yubico. "I am very pleased that Jerrod has accepted the role of acting CEO. With his extensive experience in cybersecurity and twelve years in senior leadership at Yubico, I am confident that he will lead Yubico on a continued path of growth and he will ensure Yubico maintains and strengthens its leading position. On behalf of the board, I also want to extend our sincere thanks to Mattias Danielsson for his hard work and significant contributions to Yubico’s development as a respected leader and colleague over sixteen years. We deeply appreciate his commitment to Yubico over the years," says Patrik Tigerschiöld, Chairman of the Board. "Yubico is entering an excitin
VeritasChain Unveils VAP Architecture, New Auditability Research, and Confirms Submissions to 58 Regulators Globally17.12.2025 08:00:00 CET | Press Release
VeritasChain today unveiled its Verifiable AI Provenance Framework (VAP) architecture, published new research on verifiable audit trails, and confirmed informational submissions to 58 regulatory authorities across 43 jurisdictions. These milestones advance VeritasChain’s mission to establish a global framework for verifiable auditability in AI and algorithmic trading. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216433807/en/ Map indicates jurisdictions where regulatory outreach or informational submissions have been made as of Dec 2025. Verifiable AI Provenance Framework (VAP) VAP is a layered assurance architecture designed for independent verification of AI decision-making. It is not a single product, but a framework defining how cryptographic evidence and third-party verification interoperate across diverse systems. The architecture records decision-to-execution events as immutable audit trails, facilitating regulat
Outpost24 Secures New Investment to Scale its Exposure Management and Identity Security Solutions17.12.2025 08:00:00 CET | Press Release
Outpost24, a leader in exposure management and identity security, today announced a new investment from Vitruvian Partners to fuel its next phase of global growth. This significant new funding will accelerate innovation across the company's platform, with a focus on integrating AI capabilities to optimize how security teams identify and neutralize critical vulnerabilities. The only European vendor recognized as an overall leader in the 2025 KuppingerCole Leadership Compass Report for Attack Surface Management, Outpost24 delivers a distinct approach to cyber defence that empowers security teams to gain a complete understanding of their digital and human risk landscape. Last week, Outpost24 announced the acquisition of Infinipoint, a specialist in device identity, posture validation, and secure workforce access. The acquisition marks the company's entry into the Zero Trust Workforce Access market and lays the foundation for its identity security division, Specops, to offer a unified appr
New Published Data Confirms Nemluvio ® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis17.12.2025 07:00:00 CET | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, today released new clinical data confirming nemolizumab’s rapid onset of action on itch and sleep, with significant improvements observed as early as 48 hours after treatment in some patients with atopic dermatitis and prurigo nodularis.1 The findings from post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs were published in the Journal of the European Academy of Dermatology and Venereology. Nemolizumab is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signalling of IL-31.2,5,6 IL-31 is a neuroimmune cytokine that drives itch and other symptoms in both atopic dermatitis and prurigo nodularis.3,4 These new findings reinforce the critical role of IL-31 pathway inhibition in achieving rapid itch response. Atopic dermatitis and prurigo nodularis are debilitating skin conditions that significantly affect quality of life, with symptoms such as per
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom